CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
755nm Alexandrite laserdevice
Likely dose
755nm Alexandrite laser treatmentAI-extracted
Key inclusion· 2
  • ✓Healthy non-smoking male or female, age 18-65 years (must have quit smoking ≥1 year prior)
  • ✓Willing to comply with all study requirements including biopsies, photography, post-treatment care, and all visits
Key exclusion· 13
  • ✕Pregnant, planning pregnancy during study, or breastfeeding
  • ✕Photosensitivity or use of photosensitizing medications
  • ✕Active or localized systemic infections
  • ✕Coagulation disorder or anticoagulation use (including aspirin >81 mg/day)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02091089
NCT02091089N/ACompleted
CompareCT.gov

Evaluation of the Safety and Efficacy of the Pico Laser With a Specialized Lens Array for the Treatment of Wrinkles

Cynosure, Inc.·interventional·Posted Mar 19, 2014·Updated Nov 27, 2020

In Brief

A clinical study evaluating 755nm Alexandrite laser for Wrinkles. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the efficacy and safety of the treatment of wrinkles using the picosecond 755nm Alexandrite laser.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWrinkles
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMar 19, 2014
Enrollment StartAug 1, 2013
Primary CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.3 years ago

Interventions

755nm Alexandrite laserdevice

755nm Alexandrite laser for the treatment of wrinkles